With the Affordable Care Act and political scrutiny over prescription drug prices shaking up the health care sector, it’s no mean feat to simultaneously steer a massive health insurance acquisition and a tie-up among retail pharmacies through antitrust review.
That’s what Jones Day’s Phillip Proger faces as antitrust counsel for Aetna Inc. in its proposed $37 billion acquisition of Humana Inc., and for Rite Aid Corp. as its rival, Walgreens Boots Alliance Inc., attempts a $17.2 billion buy.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
